Cash Flow Statement

Amortization Capital Expenditures Cash from Discontinued Operations Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Cash Change in Receivables Change in Working Capital Depreciation & Amortization (CF)Depreciation and Depletion Exchange Rate Effect Free Cash Flow Net Cash Flow Net Income Other Working Capital Changes Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Addex Therapeutics (ADXN) Other financing activities (2023 - 2024)

Historic Other financing activities for Addex Therapeutics (ADXN) over the last 2 years, with Q3 2024 value amounting to $6.7 billion.